Details

DSEN Abstract: Comparative Efficacy and Safety of Ultra-Long-, Long-, and Intermediate-Acting and Biosimilar Insulins for Type 1 Diabetes: A Systematic Review and Network Meta-Analysis - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Mar 31, 2026 · edition #8
Timestamp
2026-03-31T15:29:13.895Z
Language
en
ID
1225729
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview